![Christopher Towler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Towler
Direttore/Membro del Consiglio presso OBS Medical Ltd.
Profilo
Christopher Towler is a non-executive director at OBS Medical Ltd.
and Chronos Therapeutics Ltd.
He was previously a director at Alcolizer Technology United Kingdom Ltd.
and Oxford Spin-out Equity Management.
He also served as a director at Celleron Therapeutics Ltd.
and Oxtex Ltd.
Posizioni attive di Christopher Towler
Società | Posizione | Inizio |
---|---|---|
OBS Medical Ltd.
![]() OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Direttore/Membro del Consiglio | - |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christopher Towler
Società | Posizione | Fine |
---|---|---|
Oxford Spin-out Equity Management
![]() Oxford Spin-out Equity Management Investment ManagersFinance Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies. | Direttore degli Investimenti | 01/07/2015 |
Alcolizer Technology United Kingdom Ltd.
![]() Alcolizer Technology United Kingdom Ltd. Medical DistributorsDistribution Services Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom. | Direttore/Membro del Consiglio | 11/03/2014 |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Direttore/Membro del Consiglio | - |
Oxtex Ltd.
![]() Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Alcolizer Technology United Kingdom Ltd.
![]() Alcolizer Technology United Kingdom Ltd. Medical DistributorsDistribution Services Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom. | Distribution Services |
Oxford Spin-out Equity Management
![]() Oxford Spin-out Equity Management Investment ManagersFinance Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies. | Finance |
OBS Medical Ltd.
![]() OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Technology |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Health Technology |
Oxtex Ltd.
![]() Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Health Technology |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Christopher Towler